antibody radiopharmaceutical (ZielBio)

N/A

Report date: 2022/08/08 14:43:39

Base Information

Drug Nameantibody radiopharmaceutical (ZielBio)
Drug Alias NamemAb radiopharmaceutical (ZielBio)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZielbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesZielbio Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A